EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 304 filers reported holding EDITAS MEDICINE INC in Q4 2021. The put-call ratio across all filers is 3.56 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $45,013,348 | -17.7% | 5,770,942 | -13.1% | 0.00% | -33.3% |
Q2 2023 | $54,661,018 | -7.7% | 6,641,679 | -18.6% | 0.00% | 0.0% |
Q1 2023 | $59,190,385 | -63.8% | 8,164,191 | -55.7% | 0.00% | -40.0% |
Q4 2022 | $163,602,466 | +110.5% | 18,444,472 | +190.5% | 0.01% | 0.0% |
Q3 2022 | $77,709,000 | -16.6% | 6,348,781 | -19.4% | 0.01% | -16.7% |
Q2 2022 | $93,219,000 | -10.6% | 7,879,890 | +43.8% | 0.01% | +20.0% |
Q1 2022 | $104,230,000 | +19.9% | 5,480,038 | +67.3% | 0.01% | +25.0% |
Q4 2021 | $86,941,000 | -1.9% | 3,274,607 | +51.7% | 0.00% | -20.0% |
Q3 2021 | $88,651,000 | -38.2% | 2,158,018 | -14.8% | 0.01% | -37.5% |
Q2 2021 | $143,535,000 | +47.1% | 2,534,162 | +9.1% | 0.01% | +33.3% |
Q1 2021 | $97,596,000 | -38.6% | 2,323,718 | +2.6% | 0.01% | -40.0% |
Q4 2020 | $158,822,000 | +94.6% | 2,265,332 | -22.1% | 0.01% | +66.7% |
Q3 2020 | $81,614,000 | -10.5% | 2,908,563 | -5.6% | 0.01% | -14.3% |
Q2 2020 | $91,157,000 | +126.7% | 3,081,699 | +52.0% | 0.01% | +75.0% |
Q1 2020 | $40,210,000 | -31.8% | 2,027,729 | +1.9% | 0.00% | 0.0% |
Q4 2019 | $58,920,000 | +18.5% | 1,989,858 | -9.0% | 0.00% | 0.0% |
Q3 2019 | $49,721,000 | -27.1% | 2,186,517 | -20.7% | 0.00% | -20.0% |
Q2 2019 | $68,246,000 | -2.2% | 2,758,513 | -3.4% | 0.01% | 0.0% |
Q1 2019 | $69,798,000 | +42.6% | 2,854,727 | +32.7% | 0.01% | +25.0% |
Q4 2018 | $48,958,000 | -47.4% | 2,152,000 | -26.4% | 0.00% | -42.9% |
Q3 2018 | $93,032,000 | +0.0% | 2,923,738 | +12.6% | 0.01% | -12.5% |
Q2 2018 | $93,012,000 | +17.2% | 2,595,883 | +8.4% | 0.01% | +14.3% |
Q1 2018 | $79,373,000 | +7.4% | 2,394,342 | -0.5% | 0.01% | +16.7% |
Q4 2017 | $73,934,000 | +66.3% | 2,405,862 | +29.9% | 0.01% | +50.0% |
Q3 2017 | $44,464,000 | +392.8% | 1,851,924 | +244.5% | 0.00% | +300.0% |
Q2 2017 | $9,022,000 | +204.7% | 537,640 | +305.4% | 0.00% | – |
Q1 2017 | $2,961,000 | +73.4% | 132,618 | +26.1% | 0.00% | – |
Q4 2016 | $1,708,000 | +23.6% | 105,167 | +2.4% | 0.00% | – |
Q3 2016 | $1,382,000 | -43.5% | 102,691 | +2.5% | 0.00% | – |
Q2 2016 | $2,447,000 | +105.5% | 100,234 | +190.4% | 0.00% | – |
Q1 2016 | $1,191,000 | – | 34,511 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |